期刊
EXPERT OPINION ON DRUG SAFETY
卷 6, 期 2, 页码 155-164出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/14740338.6.2.155
关键词
Fanconi's syndrome; HIV; nucleotide reverse transcriptase inhibitor; renal failure; tenofovir
Tenofovir disoproxil fumarate is a nucleotide reverse transcriptase inhibitor with activity against both HIV and the hepatitis B virus. It has had minimal nephrotoxic effects in early clinical trials, but as clinical use has widened, case reports describing tenofovir-induced renal tubular damage, Fanconi's syndrome and diabetes insipidus have been described. The authors review the pharmacokinetics, mechanism of action and clinical uses of tenofovir disoproxil fumarate. The large clinical trials, as well as the case reports of tenofovir-induced kidney injury, are also reviewed. The potential mechanism of renal damage is discussed and recommendations for evaluation and treatment of tenofovir-induced kidney injury are given.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据